Add to ORKGof ERCC1 and XRCC1 predict the overall survival of advanced gastric cancer patients receiving oxaliplatin-based chemotherap
A clinical exploration of neoadjuvant chemotherapy with tegafur, gimeracil, and oteracil potassium c...
Background. Several researchers have investigated the relationship between ERCC2 rs13181 and rs17997...
This phase II trial assessed the tolerability and efficacy of a triplet of oxaliplatin, irinotecan, ...
BACKGROUND: Adjuvant chemotherapy is gaining an increasing role in resectable gastric cancer. Cus...
Purpose The aim of this study was to determine whether the ERCC1 expression is effective to predict ...
Purpose: Nucleotide excision repair (NER) modulates platinum-based chemotherapeutic efficacy by remo...
OBJECTIVE To investigate whether polymorphisms in ERC1, XPD, XPG, XRCC1 genes are associated w...
Background: Association of excision repair cross-complementing gene 1 (ERCC1) expression and treatme...
International audienceBackground: While single nucleotide polymorphisms (SNP) in genes involved in D...
Full list of author information is available at the end of the articleBackground The current standar...
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherap
. These authors contributed equally to this work. Background: Oxidative stress genes are related to ...
Except for excision repair cross-complementing 1 (ERCC1), mRNA expression of the remaining ERCC gene...
PURPOSE: ERCC1 and ERCC2 play critical roles in the nucleotide excision repair pathway that effectiv...
Background:The ACTS-GC study had shown postoperative adjuvant therapy with S-1 improved survival of ...
A clinical exploration of neoadjuvant chemotherapy with tegafur, gimeracil, and oteracil potassium c...
Background. Several researchers have investigated the relationship between ERCC2 rs13181 and rs17997...
This phase II trial assessed the tolerability and efficacy of a triplet of oxaliplatin, irinotecan, ...
BACKGROUND: Adjuvant chemotherapy is gaining an increasing role in resectable gastric cancer. Cus...
Purpose The aim of this study was to determine whether the ERCC1 expression is effective to predict ...
Purpose: Nucleotide excision repair (NER) modulates platinum-based chemotherapeutic efficacy by remo...
OBJECTIVE To investigate whether polymorphisms in ERC1, XPD, XPG, XRCC1 genes are associated w...
Background: Association of excision repair cross-complementing gene 1 (ERCC1) expression and treatme...
International audienceBackground: While single nucleotide polymorphisms (SNP) in genes involved in D...
Full list of author information is available at the end of the articleBackground The current standar...
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherap
. These authors contributed equally to this work. Background: Oxidative stress genes are related to ...
Except for excision repair cross-complementing 1 (ERCC1), mRNA expression of the remaining ERCC gene...
PURPOSE: ERCC1 and ERCC2 play critical roles in the nucleotide excision repair pathway that effectiv...
Background:The ACTS-GC study had shown postoperative adjuvant therapy with S-1 improved survival of ...
A clinical exploration of neoadjuvant chemotherapy with tegafur, gimeracil, and oteracil potassium c...
Background. Several researchers have investigated the relationship between ERCC2 rs13181 and rs17997...
This phase II trial assessed the tolerability and efficacy of a triplet of oxaliplatin, irinotecan, ...